Sample result
GLP-1, a diabetes hormone
A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.
The search
- Query
- GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
- Search
- Protein → Patent proteins · Automatic (Smith-Waterman)
- Set
- Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
- Ran
- 2026-11-12
- Found
- 5,000 sequences, 3,061 publications, 1,851 families
Smith-Waterman compares each query with every stored sequence. Each query returns up to 5,000 sequences, with the best alignment of each. FASTA36 fits its E-values to a random sample of scores, so a sequence near the cutoff can come and go between runs. These results do not establish patentability.
Patents
3,061 publications in 1,851 families match these filters.
-
WO 2026213439-A12026-10-08
GLP1R AND GIPR DUAL AGONISTS AND ANTIBODY CONJUGATES THEREOF
REGENERON PHARMA
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 1498425-A12005-01-19
Use of glucagone-like-peptide 1 (GLP-1) derivatives for the preparation of pharmaceutical compositions
The General Hospital Corporation (US)
Query Match 98.8%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 |||||||||||||||| |||||||||||||| Hit 1 HAEGTFTSDVSSYLEGZAAKEFIAWLVKGRG 3130 of 31 identical, no gaps.
-
JP 2002506792-A2002-03-05
N-terminally modified GLP-1 derivatines
NOVO NORDISK AS
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||| | Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGKG 3130 of 31 identical, no gaps.
-
US 6358924-A2002-03-19
GLP-1 formulations
Query Match 98.1%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 |||||||||||||||| |||||||||||||| Hit 1 HAEGTFTSDVSSYLEGEAAKEFIAWLVKGRG 3130 of 31 identical, no gaps.
-
US 6458924-A2002-10-01
Derivatives of GLP-1 analogs
Novo Nordisk A/S
Query Match 98.1%Identity 96.8%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||| | Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGKG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 6458924-A2002-10-01
- US 8097698-B22012-01-17
-
WO 2007090496-A12007-08-16
Synthesis of glucagon-like peptide
Lonza AG (CH)
Query Match 98.1%Identity 100.0%Family of 4
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- WO 2007090496-A12007-08-16
- JP 2009525997-A2009-07-16
- US 8445433-B22013-05-21
- US 9040480-B22015-05-26
-
WO 2009030499-A12009-03-12
Use of glp-1 analogues for the treatment of disorders associated with dysfunctional synaptic transmission
Uutech Limited (GB)
Query Match 98.1%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2009030499-A12009-03-12
- JP 2010538975-A2010-12-16
-
EP 2393828-A12011-12-14
EXTENDED RECOMBINANT POLYPEPTIDES AND COMPOSITIONS COMPRISING SAME
AMUNIX OPERATING INC
Query Match 98.1%Identity 100.0%Family of 17
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||| | Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGKG 3130 of 31 identical, no gaps.
Family of 17
Grouped by a shared priority claim, US 61/149669.
- EP 2393828-A12011-12-14
- JP 2012516854-A2012-07-26
- JP 2012529297-A2012-11-22
- US 8673860-B22014-03-18
- US 8957021-B22015-02-17
- JP 2015034165-A2015-02-19
- JP 2016106135-A2016-06-16
- US 9371369-B22016-06-21
- US 9540430-B22017-01-10
- JP 2017031218-A2017-02-09
- US 9926351-B22018-03-27
- JP 2018076378-A2018-05-17
- US 10000543-B22018-06-19
- US 10961287-B22021-03-30
- JP 2021059595-A2021-04-15
- JP 2022191465-A2022-12-27
- JP 2024081707-A2024-06-18
-
WO 2012150503-A22012-11-08
GLU-GLP-1 DUAL AGONIST SIGNALING-SELECTIVE COMPOUNDS
ZEALAND PHARMA AS
Query Match 98.1%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
WO 2014096148-A12014-06-26
FUNCTIONALIZED EXENDIN-4 DERIVATIVES
SANOFI SA
Query Match 98.1%Identity 100.0%Family of 6
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 6
Grouped by the same title and applicant. No priority claim is on record.
- WO 2014096148-A12014-06-26
- KR 1020150099548-A2015-08-31
- JP 2016503770-A2016-02-08
- US 9670261-B22017-06-06
- EP 3400957-A12018-11-14
- US 10253079-B22019-04-09
-
WO 2014096149-A12014-06-26
Exendin-4 Derivatives
SANOFI SA
Query Match 98.1%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
WO 2014096150-A12014-06-26
DUAL GLP1/GIP OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS
SANOFI SA
Query Match 98.1%Identity 100.0%Family of 4
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- WO 2014096150-A12014-06-26
- KR 1020150096433-A2015-08-24
- JP 2016503772-A2016-02-08
- US 9745360-B22017-08-29
-
EP 2796430-A12014-10-29
Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
CORNING INC
Query Match 98.1%Identity 96.8%Family of 4
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- EP 2796430-A12014-10-29
- US 9474688-B22016-10-25
- US 9839579-B22017-12-12
- US 10413482-B22019-09-17
-
WO 2014187960-A12014-11-27
REMOVAL OF N-TERMINAL EXTENSIONS FROM FUSION PROTEINS
NOVO NORDISK AS
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
WO 2014187974-A12014-11-27
FUSION PROTEASE
NOVO NORDISK AS
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
WO 2015055801-A12015-04-23
ACYLATED GLUCAGON ANALOGUES
ZEALAND PHARMA AS
Query Match 98.1%Identity 96.8%Family of 8
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 8
Grouped by the same title and applicant. No priority claim is on record.
- WO 2015055801-A12015-04-23
- KR 1020160068961-A2016-06-15
- US 9896495-B22018-02-20
- US 10457714-B22019-10-29
- US 11091528-B22021-08-17
- KR 1020220040496-A2022-03-30
- US 11884713-B22024-01-30
- US 12473339-B22025-11-18
-
WO 2015086730-A12015-06-18
NON-ACYLATED EXENDIN-4 PEPTIDE ANALOGUES
SANOFI SA
Query Match 98.1%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2015086730-A12015-06-18
- US 9750788-B22017-09-05
-
WO 2015086733-A12015-06-18
DUAL GLP-1/GLUCAGON RECEPTOR AGONISTS
SANOFI SA
Query Match 98.1%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2015086733-A12015-06-18
- US 9694053-B22017-07-04
-
US 9060991-B22015-06-23
Use of GLP-1 analogues for the treatment of disorders associated with dysfunctional synaptic transmission
Innovation Ulster Limited
Query Match 98.1%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020150096398-A2015-08-24
EXENDIN-4 DERIVATIVES AS DUAL GLP1/GIP OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS
SANOFI
Query Match 98.1%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020150096398-A2015-08-24
- JP 2016506401-A2016-03-03
-
KR 1020150096684-A2015-08-25
EXENDIN-4 DERIVATIVES
SANOFI
Query Match 98.1%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
JP 2016503771-A2016-02-08
Exendin-4 Derivatives
Sanofi
Query Match 98.1%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
US 9260474-B22016-02-16
Method for solid phase synthesis of liraglutide
HYBIO PHARMACEUTICAL CO., LTD.
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
WO 2016046753-A12016-03-31
SYNTHESIS OF GLP-1 PEPTIDES
NOVETIDE LTD
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
WO 2016067271-A12016-05-06
A PROCESS FOR THE PREPARATION OF LIRAGLUTIDE
AURO PEPTIDES LTD
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
JP 2016518855-A2016-06-30
Fusion protease
Novo Nordisk A/S
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020160142322-A2016-12-12
EXENDIN-4 DERIVATIVES AS PEPTIDIC DUAL GLP-1/GLUCAGON RECEPTOR AGONISTS
SANOFI
Query Match 98.1%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020160142322-A2016-12-12
- JP 2017519718-A2017-07-20
- US 9775904-B22017-10-03
-
WO 2017009236-A22017-01-19
NEW EXENDIN-4 DERIVATIVES AS SELECTIVE PEPTIDIC DUAL GLP-1 / GLUCAGON RECEPTOR AGONISTS
SANOFI SA
Query Match 98.1%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2017009236-A22017-01-19
- JP 2018528931-A2018-10-04
-
JP 2017512800-A2017-05-25
Peptidic dual GLP-1 / Glucagon Receptor Agonists derived from Exendin-4
Sanofi
Query Match 98.1%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2017512800-A2017-05-25
- US 9771406-B22017-09-26
-
JP 2017517483-A2017-06-29
Dual GLP-1 / Glucagon Receptor Agonists derived from Exendin-4
Sanofi
Query Match 98.1%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2017517483-A2017-06-29
- US 9758561-B22017-09-12
-
EP 3196206-A12017-07-26
METHOD FOR PREPARATION OF LIRAGLUTIDE
LONZA AG
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
EP 3196207-A12017-07-26
METHOD FOR PREPARATION OF PEPTIDES WITH PSWANG LINKER
LONZA AG
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
JP 2017520261-A2017-07-27
Dual cistronic bacterial expression system
LUPIN LIMITED
Query Match 98.1%Identity 96.8%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- JP 2017520261-A2017-07-27
- US 10329571-B22019-06-25
- US 11365418-B22022-06-21
-
EP 3205660-A12017-08-16
METHOD FOR PREPARATION OF PEPTIDES WITH PSWANG LINKER
POLYPEPTIDE LABORATORIES HOLDING (PPL) AB
Query Match 98.1%Identity 96.8%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- EP 3205660-A12017-08-16
- EP 3405476-A12018-11-28
- US 11236123-B22022-02-01
-
EP 3205664-A12017-08-16
METHOD FOR PREPARATION OF LIRAGLUTIDE USING BAL LINKER
POLYPEPTIDE LABORATORIES HOLDING (PPL) AB
Query Match 98.1%Identity 96.8%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 3205664-A12017-08-16
- EP 3414257-A12018-12-19
-
US 9751926-B22017-09-05
Dual GLP-1/GIP receptor agonists
SANOFI
Query Match 98.1%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
JP 2017525656-A2017-09-07
GLP-1/GLUCAGON RECEPTOR CO-AGONISTS FOR MEDICAL USE
NOVO NORDISK A/S
Query Match 98.1%Identity 96.8%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2017525656-A2017-09-07
- US 10570184-B22020-02-25
-
US 9789165-B22017-10-17
Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists
SANOFI
Query Match 98.1%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
WO 2017186934-A12017-11-02
DIPEPTIDYL PEPTIDASE-4 INHIBITORS FOR TOPICAL EYE TREATMENT OF RETINAL NEURODEGENERATIVE DISEASES
FUNDACI HOSPITAL UNIV VALL D'HEBRON - INST DE RECERCA
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
WO 2018069295-A12018-04-19
METHOD OF PREPARING PEPTIDES COMPRISING A LIPOPHILICALLY MODIFIED LYSINE SIDE CHAIN
SANOFI SA
Query Match 98.1%Identity 100.0%Family of 4
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- WO 2018069295-A12018-04-19
- KR 1020190059321-A2019-05-30
- JP 2019533666-A2019-11-21
- US 11021512-B22021-06-01
-
US 9982029-B22018-05-29
Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists
SANOFI
Query Match 98.1%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
WO 2018100134-A12018-06-07
NEW COMPOUNDS AS PEPTIDIC TRIGONAL GLP1/GLUCAGON/GIP RECEPTOR AGONISTS
SANOFI SA
Query Match 98.1%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- WO 2018100134-A12018-06-07
- KR 1020190085141-A2019-07-17
- JP 2019536796-A2019-12-19
-
WO 2018100135-A12018-06-07
NEW COMPOUNDS AS PEPTIDIC GLP1/GLUCAGON/GIP RECEPTOR AGONISTS
SANOFI SA
Query Match 98.1%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- WO 2018100135-A12018-06-07
- KR 1020190086022-A2019-07-19
- JP 2019536795-A2019-12-19
-
WO 2018100174-A12018-06-07
CONJUGATES COMPRISING AN GLP-1/GLUCAGON DUAL AGONIST, A LINKER AND HYALURONIC ACID
SANOFI SA
Query Match 98.1%Identity 96.8%Family of 5
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 5
Grouped by the same title and applicant. No priority claim is on record.
- WO 2018100174-A12018-06-07
- KR 1020190091482-A2019-08-06
- JP 2020503278-A2020-01-30
- US 10792367-B22020-10-06
- US 11141489-B22021-10-12
-
JP 2018518485-A2018-07-12
PROTEASE-RESISTANT LIPIDATED GLP-1 ANALOGS
MEDIMMUNE LIMITED
Query Match 98.1%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2018518485-A2018-07-12
- US 10414811-B22019-09-17
-
WO 2018172921-A12018-09-27
EXPRESSION AND LARGE-SCALE PRODUCTION OF PEPTIDES
LUPIN LTD
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
EP 3429608-A12019-01-23
EXTENDED RELEASE CONJUGATES OF EXENATIDE ANALOGS
PROLYNX LLC
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
WO 2019030268-A12019-02-14
GLP-1/GLUCAGON RECEPTOR AGONISTS IN THE TREATMENT OF FATTY LIVER DISEASE AND STEATOHEPATITIS
SANOFI SA
Query Match 98.1%Identity 96.8%Family of 4
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- WO 2019030268-A12019-02-14
- KR 1020200037358-A2020-04-08
- JP 2020530017-A2020-10-15
- US 11352405-B22022-06-07
-
EP 3448417-A12019-03-06
INSULIN DIMER-INCRETIN CONJUGATES
MERCK SHARP & DOHME
Query Match 98.1%Identity 96.8%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 3448417-A12019-03-06
- US 11058775-B22021-07-13
-
WO 2019069274-A12019-04-11
A PROCESS FOR PREPARING A GLUCAGON-LIKE PEPTIDE
CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S A
Query Match 98.1%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.